Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Change in Cash (2019 - 2026)

Alx Oncology Holdings' Change in Cash history spans 5 years, with the latest figure at $2.8 million for Q4 2023.

  • On a quarterly basis, Change in Cash rose 1316.38% to $2.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$26.4 million, a 91.61% increase, with the full-year FY2025 number at -$1.2 million, up 75.33% from a year prior.
  • Change in Cash hit $2.8 million in Q4 2023 for Alx Oncology Holdings, up from -$18.5 million in the prior quarter.
  • Over the last five years, Change in Cash for ALXO hit a ceiling of $174.7 million in Q4 2020 and a floor of -$204.5 million in Q1 2022.
  • Historically, Change in Cash has averaged $743555.6 across 5 years, with a median of -$5.6 million in 2020.
  • Biggest five-year swings in Change in Cash: surged 5509.47% in 2020 and later tumbled 4586.41% in 2022.
  • Tracing ALXO's Change in Cash over 5 years: stood at $3.1 million in 2019, then surged by 5509.47% to $174.7 million in 2020, then plummeted by 112.29% to -$21.5 million in 2021, then soared by 98.92% to -$232000.0 in 2022, then skyrocketed by 1316.38% to $2.8 million in 2023.
  • Business Quant data shows Change in Cash for ALXO at $2.8 million in Q4 2023, -$18.5 million in Q3 2023, and -$25.2 million in Q2 2023.